Adam Torbicki

Summary

Affiliation: National Institute of Tuberculosis and Lung Diseases
Country: Poland

Publications

  1. doi Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)
    Adam Torbicki
    Department of Chest Medicine, Institute for Tuberculosis and Lung Diseases, Warsaw, Poland
    Eur Heart J 29:2276-315. 2008
  2. ncbi Pulmonary embolism: role of echocardiography and of biological markers
    Adam Torbicki
    Department of Chest Medicine, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
    Ital Heart J 6:805-10. 2005
  3. ncbi Pulmonary arterial hypertension: evaluation of the newly diagnosed patient
    Adam Torbicki
    Department of Chest Medicine, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
    Semin Respir Crit Care Med 26:372-8. 2005
  4. ncbi Pulmonary thromboembolic disease. Clinical management of acute and chronic disease
    Adam Torbicki
    National Institute for Tuberculosis and Lung Diseases, Warsaw, Poland
    Rev Esp Cardiol 63:832-49. 2010
  5. ncbi Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension
    Marcin Kurzyna
    Department of Chest Medicine, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01 138 Warsaw, Poland
    Chest 131:977-83. 2007
  6. ncbi Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension
    Adam Torbicki
    Department of Chest Medicine, Institute of Tuberculosis and Lung Diseases, Medical University of Warsaw, Poland
    Circulation 108:844-8. 2003
  7. ncbi Characteristics and prognosis of patients with decompensated right ventricular failure during the course of pulmonary hypertension
    Marcin Kurzyna
    Department of Chest Medicine, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
    Kardiol Pol 66:1033-9; discussion 1040-1. 2008
  8. ncbi Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study
    Grzegorz Opolski
    Department of Cardiology, Medical University of Warsaw, Warsaw, Poland
    Chest 126:476-86. 2004
  9. ncbi Atrial septostomy for severe primary pulmonary hypertension - report on two cases
    Marcin Kurzyna
    Department of Chest Medicine, Institute of Tuberculosis and Lung Diseases, Bielanski Hospital, Warsaw, Poland
    Kardiol Pol 58:27-33. 2003
  10. ncbi Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension
    Anna Fijalkowska
    Department of Chest Medicine, National Research Institute of Tuberculosis and Lung Diseases, Ul Plocka 26, 01 138 Warsaw, Poland
    Chest 129:1313-21. 2006

Detail Information

Publications59

  1. doi Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)
    Adam Torbicki
    Department of Chest Medicine, Institute for Tuberculosis and Lung Diseases, Warsaw, Poland
    Eur Heart J 29:2276-315. 2008
    ..With the exception of severe air and fat embolism, the haemodynamic consequences of non-thrombotic emboli are usually mild. Treatment is mostly supportive but may differ according to the type of embolic material and clinical severity...
  2. ncbi Pulmonary embolism: role of echocardiography and of biological markers
    Adam Torbicki
    Department of Chest Medicine, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
    Ital Heart J 6:805-10. 2005
    ....
  3. ncbi Pulmonary arterial hypertension: evaluation of the newly diagnosed patient
    Adam Torbicki
    Department of Chest Medicine, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
    Semin Respir Crit Care Med 26:372-8. 2005
    ..Biomarkers seem particularly useful for noninvasive follow-up of patients with PAH, and due to simplicity and low costs may successfully compete with echocardiography...
  4. ncbi Pulmonary thromboembolic disease. Clinical management of acute and chronic disease
    Adam Torbicki
    National Institute for Tuberculosis and Lung Diseases, Warsaw, Poland
    Rev Esp Cardiol 63:832-49. 2010
    ....
  5. ncbi Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension
    Marcin Kurzyna
    Department of Chest Medicine, National Tuberculosis and Lung Diseases Research Institute, Plocka 26, 01 138 Warsaw, Poland
    Chest 131:977-83. 2007
    ..Right ventricular (RV) failure is the main cause of death in patients with pulmonary hypertension (PH). Balloon atrial septostomy (BAS) is believed to relieve symptoms of PH by increasing systemic flow and reducing RV preload...
  6. ncbi Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension
    Adam Torbicki
    Department of Chest Medicine, Institute of Tuberculosis and Lung Diseases, Medical University of Warsaw, Poland
    Circulation 108:844-8. 2003
    ..We checked whether detection of cardiac troponin T (cTnT), a specific marker of myocyte injury, could be useful in prognostic stratification of those patients...
  7. ncbi Characteristics and prognosis of patients with decompensated right ventricular failure during the course of pulmonary hypertension
    Marcin Kurzyna
    Department of Chest Medicine, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
    Kardiol Pol 66:1033-9; discussion 1040-1. 2008
    ..The optimal approach in DRHF has not been established yet...
  8. ncbi Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study
    Grzegorz Opolski
    Department of Cardiology, Medical University of Warsaw, Warsaw, Poland
    Chest 126:476-86. 2004
    ..The relative risks and benefits of strategies of rate control vs rhythm control in patients with atrial fibrillation (AF) remain to be fully explored...
  9. ncbi Atrial septostomy for severe primary pulmonary hypertension - report on two cases
    Marcin Kurzyna
    Department of Chest Medicine, Institute of Tuberculosis and Lung Diseases, Bielanski Hospital, Warsaw, Poland
    Kardiol Pol 58:27-33. 2003
    ..In view of poor prognosis and limited therapeutic options in Poland, elective AS should be considered as a potentially valuable intervention in patients with primary PH in our country...
  10. ncbi Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension
    Anna Fijalkowska
    Department of Chest Medicine, National Research Institute of Tuberculosis and Lung Diseases, Ul Plocka 26, 01 138 Warsaw, Poland
    Chest 129:1313-21. 2006
    ..Serum samples for NT-proBNP were secured, and 6-min walk test (6 MWT), RV catheterization, and echocardiography were all performed on the same day, before the introduction of targeted treatment...
  11. ncbi Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism
    Piotr Pruszczyk
    Department of Internal Medicine and Hypertension, Medical University of Warsaw, Warsaw, Poland
    Chest 123:1947-52. 2003
    ..01 ng/mL) at hospital admission, and subsequently three times at 6-h intervals. Heparin therapy alone was used in 87.5% of patients, while 12.5% of patients received thrombolysis...
  12. pmc In search of markers of treatment failure and poor prognosis in IPAH - the value of mosaic lung attenuation pattern on thin-section CT scans
    Monika Szturmowicz
    Department of Internal Medicine, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland
    Multidiscip Respir Med 5:409-16. 2010
    ..The present review is focused on the radiological features suggestive of PVOD-like vasculopathy in PAH...
  13. ncbi Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry
    Adam Torbicki
    Department of Chest Medicine, Institute of Tuberculosis and Lung Disease, Warsaw, Poland
    J Am Coll Cardiol 41:2245-51. 2003
    ..This study was designed to investigate the prevalence and prognostic significance of right heart thrombi (RHTh) in pulmonary embolism...
  14. ncbi Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism
    Marcin Kurzyna
    Department of Chest Medicine and Division of Radiology, Institute of Tuberculosis and Lung Disease, Warsaw, Poland
    Am J Cardiol 90:507-11. 2002
    ..Combining these 2 signs may increase the sensitivity without compromising the specificity of echocardiographic diagnosis of APE...
  15. doi Recurrent hemoptysis: an emerging life-threatening complication in idiopathic pulmonary arterial hypertension
    Joanna Zyłkowska
    Department of Chest Medicine, Institute of Tuberculosis and Lung Diseases, 1, Plocka 26, 01 138 Warsaw, Poland
    Chest 139:690-3. 2011
    ..Repeated BAE should not be considered as a definitive treatment in patients with pulmonary arterial hypertension with recurrent bleeding, although it may help in bridging patients to lung transplant...
  16. ncbi Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study
    Grzegorz Opolski
    Chair and Department of Internal Medicine and Cardiology, Medical Academy, Warsaw, Poland
    Kardiol Pol 59:1-16; discussion 15-16. 2003
    ..Which of these two strategies is superior, has not yet been definitively established...
  17. ncbi [Interstitial pneumonitis in a patient treated with amiodarone -- case report]
    Anna Paczek
    Klinika Chorob Wewnetrznych Klatki Piersiowej Instytutu Gruzlicy i Chorob Pluc w Warszawie, Poland
    Pneumonol Alergol Pol 76:118-24. 2008
    ..Regression of pulmonary symptoms and improvement of ventilatory parameters were observed after 3 months of treatment. Pathogenesis, diagnostic procedures and current methods of treatment of this jatrogenic disease are discussed...
  18. ncbi [A case of a patient with idiopathic pulmonary arterial hypertension treated with lung transplantation: a "bumpy road" to success]
    Liliana Wawrzynska
    Klinika Chorób Wewnetrznych Klatki Piersiowej Instytutu Gruźlicy i Chorób Płuc
    Pol Arch Med Wewn 115:565-71. 2006
    ..We consider good long term outcome as assessed 26 months post transplantation as an encouragement for other attempts at lung transplantation in patients with IPAH and for development of this method of therapy in Poland...
  19. ncbi Primary Sjögren's Syndrome with two extraglandular sites involvement - case report
    Monika Szturmowicz
    Department of Chest Medicine, National Tuberculosis and Lund Diseases Research Institute, Warsaw, Poland
    Pneumonol Alergol Pol 78:445-50. 2010
    ..In 40-60% of pSS patients, extraglandular disease develops. We present the case of a patient with two extraglandular sites involvement in the course of pSS manifesting with progressive respiratory and gastrointestinal symptoms...
  20. ncbi The recurrence after ten years - "mother in-law variant" of tako-tsubo syndrome
    Grzegorz Opolski
    Department of Cardiology, Warsaw Medical University, Warsaw, Poland
    Kardiol Pol 68:557-61. 2010
    ..Little data exists regarding the recurrence of the disease, especially over the long-term follow-up. We present a case of relapse of LVAB after ten years...
  21. ncbi Predictive value of RT-PCR PML-RARA transcript monitoring for extramedullary relapse of acute promyelocytic leukemia in the pleura, heart and pericardium after allogeneic SCT
    Barbara Nasilowska-Adamska
    Bone Marrow Transplantation Unit, Institute of Hematology and Blood Transfusion, Warsaw, Poland
    Ann Transplant 12:33-8. 2007
    ....
  22. ncbi [Right ventricle structure and function in patients with obstructive sleep apnea (OSA)]
    Jarosław Kober
    Klinika Chorób Wewnetrznych Klatki Piersiowej w Warszawie
    Pol Arch Med Wewn 111:455-65. 2004
    ..CONCLUSIONS: Enlargement and functionally compromised RV is found in OBS mostly with concomitant obesity. Pulmonary hypertension at rest in patients with isolated OSA is rare and also requires additional contributing factors...
  23. ncbi Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension
    Nazzareno Galie
    Institute of Cardiology, University of Bologna, Italy
    J Am Coll Cardiol 41:1380-6. 2003
    ..The purpose of this study was to investigate the effects of bosentan (125 or 250 mg twice daily) on echocardiographic and Doppler variables in 85 patients with World Health Organization class III or IV pulmonary arterial hypertension (PAH)...
  24. ncbi Factors determining long-term maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation
    Dariusz Kosior
    Chair and Department of Cardiology, Medical University of Warsaw, Poland
    Kardiol Pol 59:128-41; commentary 141. 2003
    ..Long-term maintenance of sinus rhythm (SR) after successful cardioversion (CV) of persistent atrial fibrillation (AF) carries a low risk of stroke and may avoid the risks associated with anticoagulation...
  25. ncbi Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial
    Nazzareno Galie
    Institute of Cardiology, University of Bologna, Bologna, Italy
    J Am Coll Cardiol 39:1496-502. 2002
    ....
  26. ncbi [Unusual cause of right heart failure decompensation in 21-years old patient with idiopathic pulmonary arterial hypertension -- a case report]
    Michał Florczyk
    Klinika Chorob Wewnetrznych Klatki Piersiowej, Instytut Gruźlicy i Chorób Płuc w Warszawie
    Pneumonol Alergol Pol 75:95-9. 2007
    ..This case demonstrates that bleeding should be also considered in differential diagnosis of exacerbation of right ventricular failure in patients with pulmonary arterial hypertension...
  27. ncbi [Effect of long-term therapy with oral Beraprost on survival of patients with arterial and inoperable thromboembolic pulmonary hypertension]
    Marcin Kurzyna
    Klinika Chorób Wewnetrznych, Instytutu Gruźlicy i Chorób Płuc w Warszawie
    Pol Arch Med Wewn 111:477-82. 2004
    ..These results suggest, that BPS improves prognosis of patients with precapillary PH during 12 months after initiation of therapy. Later effect of BPS seems to decrease, requiring changing or intensification of therapy...
  28. ncbi [Effect of localization of pulmonary arterial changes on echocardiographic indices of right heart function and their correlation with exercise capacity: comparison of arterial and thromboembolic pulmonary hypertension]
    Paweł Kuca
    Klinika Chorób Wewnetrznych, Klatki Piersiowej Instytutu Gruźlicy i Chorób Płuc w Warszawie
    Pol Arch Med Wewn 111:467-75. 2004
    ..To assess correlation between exercise tolerance and Doppler-derived indices of right ventricular (RV)--pulmonary arterial coupling in patients with different location of vascular lesions causing pulmonary hypertension (PH)...
  29. ncbi [Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation]
    Dariusz Kosior
    Katedra i Klinika Chorób Wewnetrznych i Kardiologii I Wydziału Lekarskiego AM w Warszawie
    Pol Arch Med Wewn 108:1151-60. 2002
    ..Following an unsuccessful first CV pts received loading dose amiodarone and another CV was attempted. In case of SR restoration amiodarone was administered continuously...
  30. ncbi Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable?
    Dariusz A Kosior
    Department of Cardiology, Medical University of Warsaw, Banacha str 1A, 02 097 Warsaw, Poland
    Heart Vessels 21:375-81. 2006
    ..83; 95% confidence interval: 1.03-2.95; P < 0.01). Of all the considered variables only LA area and FS value seem to be relatively reliable predictors of SR sustainability at 1 year after an effective cardioversion of persistent AF...
  31. ncbi [Pulmonary hypertension--some problems resolved. More remain to be solved]
    Adam Torbicki
    Klinika Chorób Wewnetrznych Instytutu Gruźlicy i Chorób Płuc w Warszawie
    Pol Arch Med Wewn 111:423-9. 2004
    ..Such methods should allow better timing of atrial septostomy and listing for lung transplantation...
  32. ncbi [Feasibility of home self-administration of low molecular weight heparin by patients with atrial fibrillation recurrence. A new approach to thromboembolic prophyllaxis]
    Dariusz A Kosior
    Katedra i Klinika Kardiologii i Wydziału Lekarskiego AM w Warszawie
    Pol Arch Med Wewn 114:1204-11. 2005
    ..We checked the feasibility of self-screening for atrial fibrillation (AF) by instructed patients pts and prompt home self-administration of an initial dose of low-molecular weight heparin (LMWH) prior to seeking medical attention...
  33. ncbi [Guidelines on diagnosis and treatment of pulmonary arterial hypertension]
    Nazzareno Galie
    Institute of Cardiology, University of Bologna, Italy
    Rev Esp Cardiol 58:523-66. 2005
  34. ncbi 'Syringe-in-the-pocket'--a new approach to the outpatient thromboembolic prophylaxis of recurrent atrial fibrillation
    Dariusz A Kosior
    Cardiology 107:370-2. 2007
    ..CONCLUSION: When properly trained, the majority of patients can accurately diagnose AF recurrence and self-inject an initial dose of LMWH, which makes it a feasible and potentially attractive anti-thromboembolic strategy...
  35. ncbi [Vascular complications in a 51-year-old female with a primary antiphospholipd syndrome--a case report]
    Maria Wieteska
    Klinika Chorob Wewnetrznych Klatki Piersiowej, Instytut Gruźlicy i Chorób Płuc, ul Płocka 26, Warszawa
    Kardiol Pol 65:50-3. 2007
    ....
  36. ncbi Cardiac magnetic resonance in pulmonary arterial hypertension: a step in the right direction
    Adam Torbicki
    Eur Heart J 28:1187-9. 2007
  37. ncbi Polish forum for prevention guidelines on cardiovascular diseases prevention in women
    Zdzisława Kornacewicz-Jach
    Kardiol Pol 65:334-7. 2007
  38. ncbi Polish Forum for Prevention Guidelines on the so-called new cardiovascular risk factors and markers, which have a potentially significant role in the strategy for the prevention of cardiovascular diseases
    Anetta Undas
    Polish Society of Internal Medicine
    Kardiol Pol 65:1396-8. 2007
  39. ncbi [Differential diagnosis of pneumonia and pulmonary embolism]
    Joanna Wisniewska
    Instytut Gruźlicy i Chorób Płuc, Warszawa
    Pneumonol Alergol Pol 70:409-12. 2002
    ..D-dimer test, venous ultrasonography and spiral-CT were used to rule out suspected PE. Bilateral pneumonia was diagnosed. Difficulties in the differential diagnosis of pneumonia and PE are discussed...
  40. ncbi Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension
    Rajiv D Machado
    Division of Medical Genetics, Department of Genetics, University of Leicester, Leicester, United Kingdom
    Hum Mutat 27:121-32. 2006
    ....
  41. ncbi [Pulmonary hypertension--management strategies]
    Adam Torbicki
    Klinika Chorob Wewnetrznych Klatki Piersiowej, Instytut Gruźlicy i Chorób Płuc w Warszawie
    Pneumonol Alergol Pol 71:543-9. 2003
  42. ncbi End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives
    Marius M Hoeper
    Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany
    J Am Coll Cardiol 43:48S-55S. 2004
    ..Finally, cardiopulmonary exercise testing, echocardiographic studies, and biochemical parameters, such as brain natriuretic peptide or troponin T, may also prove useful as secondary end points in the future...
  43. ncbi Diagnosis and differential assessment of pulmonary arterial hypertension
    Robyn J Barst
    Columbia University College of Physicians and Surgeons, New York, New York, USA
    J Am Coll Cardiol 43:40S-47S. 2004
    ..Close follow-up at a center specializing in management of PH is recommended, with careful periodic reassessment and adjustment of therapy...
  44. ncbi [Pulmonary thromboembolism as a late complication of mitochondrial myopathy (Kearns-Sayer syndrome ]
    Justyna Fijołek
    III Kliniki Chorób Płuc IGiCHP w Warszawie
    Pneumonol Alergol Pol 71:449-57. 2003
    ..Diagnosis was confirmed by EMG examination and muscle biopsy...
  45. ncbi Myoglobin stratifies short-term risk in acute major pulmonary embolism
    Piotr Pruszczyk
    Department of Internal Medicine and Hypertension, Medical University of Warsaw, Banacha 1a, 02 097 Warsaw, Poland
    Clin Chim Acta 338:53-6. 2003
    ..Therefore, we assessed prevalence and prognostic significance of myoglobin in major APE...
  46. ncbi Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension
    Marius M Hoeper
    Dept of Respiratory Medicine, Hannover Medical School, 30623 Hannover, Germany
    Am J Respir Crit Care Med 165:341-4. 2002
    ..Our data indicate that CPR for circulatory arrest in patients with PAH is rarely successful unless the cause of the cardiopulmonary decompensation can be corrected...
  47. ncbi Management of grown up congenital heart disease
    John Deanfield
    GUCH Unit, The Heart Hospital, London
    Eur Heart J 24:1035-84. 2003
  48. ncbi Cardiac troponins in acute pulmonary embolism
    Piotr Pruszczyk
    Chest 122:2264; author reply 2264-5. 2002
  49. ncbi [Value of spiral computed tomography in pulmonary hypertension]
    Barbara Burakowska
    Zakład Radiologii Instytutu Gruźlicy i Chorób Płuc w Warszawie
    Pol Arch Med Wewn 111:431-41. 2004
    ..Pulmonary hypertension (PH) represents an important diagnostic problem, because of its non-specific clinical presentation...
  50. ncbi [Inhaled nitric oxide (NO) for vasoreactivity testing in pulmonary hypertension]
    Janusz Burakowski
    Klinika Chorób Wewnetrznych Kłatki Piersiowej, Instytutu Gruźlicy i Chorób Płuc w Warszawie
    Pol Arch Med Wewn 111:443-8. 2004
    ..2. It allows for stratification of patients according to the degree of preserved pulmonary vascular reactivity. However, criteria which would permit to select optimal treatment based on the results of NO test require further studies...
  51. ncbi [Mycobacterium kansasii infection in chronic thromboembolic pulmonary hypertension (CTEPH), report of two cases]
    Monika Szturmowicz
    Kliniki Chor6ób Wewnetrznych Klatki Piersiowej, Warszawa
    Pneumonol Alergol Pol 72:523-9. 2004
    ..These are to our knowledge the first recognized cases of M. Kansasii infection in CTEPH. Chronic hypoxemia with impaired lung metabolism could be responsible for susceptibility to infection with nonpathogenic subtype 4 of M. Kansasii...
  52. ncbi Sildenafil citrate therapy for pulmonary arterial hypertension
    Nazzareno Galie
    Institute of Cardiology, University of Bologna, Bologna, Italy
    N Engl J Med 353:2148-57. 2005
    ....
  53. ncbi A decrease of enlarged left atrium following cardioversion of atrial fibrillation predicts the long-term maintenance of sinus rhythm
    Dariusz A Kosior
    1st Chair and Department of Cardiology
    Kardiol Pol 62:428-37; discussion 438-9. 2005
    ..Aim. We sought to determine the role of LA enlargement in long-term SR maintenance after CV of persistent AF...
  54. ncbi [Autoimmune thyroid diseases in patients with primary pulmonary hypertension]
    Liliana Wawrzynska
    Klinika Chorob Wewnetrznych Klatki Piersiowej, Instytut Gruźlicy i Chorób Płuc, Warszawa
    Pneumonol Alergol Pol 72:19-22. 2004
    ..The purpose of this study was the prospective determination of autoimmune thyroid status in PPH patients...
  55. ncbi Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology
    Nazzareno Galie
    Eur Heart J 25:2243-78. 2004
  56. ncbi [Lung transplantation for end-stage pulmonary hypertension]
    Monika Szturmowicz
    Klinika Chorób Wewnetrznych, Klatki Piersiowej, Instytutu Gruźlicy i Chorób Płuc
    Pol Arch Med Wewn 111:511-9. 2004
  57. ncbi [Scimitar syndrome--case report]
    Liliana Wawrzynska
    Klinika Chorób Wewnetrznych, Klatki Piersiowej, Instytutu Gruźlicy i Chorób Płuc
    Pol Arch Med Wewn 111:489-93. 2004
    ..Other cause of pulmonary hypertension is atrial septum defect. Our patient required permanent pacemaker implantation for tachy-brady syndrome...
  58. ncbi [Pulmonary thrombendarterectomy in a patient with chronic thromboembolic pulmonary hypertension (CTEPH) and chronic renal failure due to diabetic nephropathy--case report]
    Anna Stawecka-Pawelczyk
    Klinika Chorób Wewnetrznych, Klatki Piersiowej, Instytutu Gruźlicy i Chorób Płuc w Warszawie
    Pol Arch Med Wewn 111:483-7. 2004
    ..During follow-up anticoagulant prophylaxis and hemodialysis are continued. It might be conducted that pulmonary thrombendarterectomy can be successfully performed also in patients with complex coexisting conditions...
  59. ncbi [Pulmonary embolism in course of deep vein thrombosis of lower extremities in patient wit bilateral femoral bone fracture after car accident injuries]
    Krzysztof Lewandowski
    Klinika Chorób Wewnetrznych Klatki Piersiowej Instytutu Gruźlicy i Chorób Płuc w Warszawie
    Pneumonol Alergol Pol 70:203-9. 2002
    ..We present a case of 46 years old man with bilateral fracture of femoral bone after car accident injury in whom signs of deep venous thrombosis and pulmonary embolism were observed despite the use of anticoagulant prophylaxis...